FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Zydus Pharmaceuticals Benzonatate Capsules Recall

Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila…

Zydus Pharmaceuticals USA Inc · Pennington, NJ

Risk level
Class II
Reported by FDA
Dec 24, 2014
Recall ID
D-0299-2015
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals recalled Benzonatate Capsules starting Nov 26, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0299-2015 on Dec 24, 2014. Reason: Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

Product description

Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; NDC 68382-248-01, UPC 3 68382 24801 5.

Lot numbers, UPCs & expiration codes

Lot #: MP2137, MP2138, MP2139, Exp 01/16; MP3614, Exp 03/16; MP5611, MP5613, Exp 05/16

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0299-2015
Classification
Class II
Status
Terminated
Recall initiated
Nov 26, 2014
FDA report date
Dec 24, 2014
Quantity
58,920 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals USA Inc

Original FDA data

Every field from FDA enforcement report D-0299-2015, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Terminated
Country
United States
Event ID
69911
Address
73 Route 31 N
Code information
Lot #: MP2137, MP2138, MP2139, Exp 01/16; MP3614, Exp 03/16; MP5611, MP5613, Exp 05/16
Postal code
08534-3601
Report date
Dec 24, 2014
Product type
Drugs
Recall number
D-0299-2015
Classification
Class II
Recalling firm
Zydus Pharmaceuticals USA Inc
Product quantity
58,920 bottles
Termination date
Sep 25, 2017
Reason for recall
Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; NDC 68382-248-01, UPC 3 68382 24801 5.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Nov 26, 2014
Initial firm notification
Letter
Center classification date
Dec 16, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0299-2015, published Dec 24, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls